Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 study
Titel:
Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 study
Auteur:
Rutherford, Sarah C Abramson, Jeremy S Bartlett, Nancy L Barta, Stefan K Khan, Nadia Joyce, Robin Maddocks, Kami Ali-Shaw, Trisha Senese, Silvia Yuan, Ying Westin, Jason Leonard, John P